Filing Details
- Accession Number:
- 0001237899-12-000092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-12-03 16:21:39
- Reporting Period:
- 2012-11-29
- Filing Date:
- 2012-12-03
- Accepted Time:
- 2012-12-03 16:21:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1487767 | S Michael Aberman | 777 Old Saw Mill River Road Tarrytown NY 10591 | Vp Strategy And Investor Relat | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-11-29 | 8,334 | $24.00 | 18,834 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-11-29 | 1,097 | $182.20 | 17,737 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2012-11-29 | 3,333 | $182.20 | 14,404 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2012-11-30 | 3,004 | $180.08 | 11,400 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-30 | 400 | $181.59 | 11,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-30 | 200 | $182.39 | 10,800 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-30 | 200 | $183.77 | 10,600 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-30 | 100 | $184.00 | 10,500 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-11-29 | 8,334 | $0.00 | 8,334 | $24.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 50,002 | 2020-03-22 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 287 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 3,004 shares of Company stock on November 30, 2012 at prices ranging from $180.00 to $180.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.
- Represents volume-weighted average price of sales of 400 shares of Company stock on November 30, 2012 at prices ranging from $181.29 to $181.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on November 30, 2012 at prices ranging from $182.38 to $182.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on November 30, 2012 at prices ranging from $183.64 to $183.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 30, 2012 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests over five years, commencing one year after the date of grant. 12,500 options vest on the first anniversary, 25,000 options vest on the second anniversary, 25,000 options vest on the third anniversary, 25,000 options vest on the fourth anniversary, and 12,500 options vest on the fifth anniversary of the date of grant.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
Billionaire Hedge Funds
